Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

A Randomized Placebo-controlled Pilot Study of Single-dose Intraoperative Ketamine for the Prevention of Delirium in Otolaryngeal Cancer Surgery Patients

To see complete record on, please visit this link

Id: NCT03040024

Organisation Name: Emory University

Overal Status: Terminated

Start Date: March 17, 2017

Last Update: July 8, 2021

Lead Sponsor: Emory University

Brief Summary: The goal of this prospective randomized double blinded placebo controlled study is to investigate if a single dose of ketamine in addition to standard anesthesia will reduce the risk of delirium in otolaryngeal cancer patients postoperatively. Ketamine's effect on post-operative pain and opioid use will be measured as well. Electroencephalogram (EEG) will be utilized during the surgical procedure to evaluate its potential as a possible predictive device for delirium.

  • Otolaryngeal Cancer

Total execution time in seconds: 3.1818740367889